ScienceDirect Available online at www.sciencedirect.com Volume XXX, Supplement 1, XX 202X ISSN XXXX Abstracts of RESUSCITATION 2025 23rd October – 25th October 2025 Rotterdam, Netherlands ISSN 0300-9572 Volume 215, Supplement 3, November 2025
RESUSCITATION Official Journal of the European Resuscitation Council also affiliated with the American Heart Association, the Australian Resuscitation Council, the New Zealand Resuscitation Council, the Resuscitation Council of Southern Africa and the Japan Resuscitation Council EDITOR-IN-CHIEF: Jerry P. Nolan, Bath, UK EDITORS: Shir Lynn Lim, Singapore Michael Parr, Sydney, Australia Gavin D. Perkins, Warwick, UK Jasmeet Soar, Bristol, UK EDITOR EMERITUS: Douglas Chamberlain, Brighton, UK STATISTICAL ADVISOR: Robin Prescott (UK) SOCIAL MEDIA EDITOR: Tommaso Scquizzato (Italy) EDITORIAL BOARD Benjamin Abella (USA) Cristian Abelairas-Gomez (Spain) Lars Andersen (Denmark) Anders Aneman (Denmark) Tom P. Aufderheide (USA) Charles Babbs (USA) Carolina Barbosa Maciel (USA) Ben Beck (Australia) Lance B. Becker (USA) Robert Berg (USA) Leo Bossaert (Belgium) Martin Botha (South Africa) Bernd W. Böttiger (Germany) Janet Bray (Australia) Clif Callaway (USA) Alain Cariou (France) Pierre Carli (France) Sheldon Cheskes (Canada) Keith Couper (UK) Tobias Cronberg (Sweden) Charles Deakin (UK) Alan De Caen (Canada) Ian Drennan (Canada) Michael Donnino (USA) Jonathan Elmer (USA) Judith Finn (Australia) Cornelia Genbrugge (Belgium) Romergryko Geocadin (USA) Jan-Thorsten Gräsner (Germany) Cornelia Genbrugge (Belgium) Kirstie Haywood (UK) Peter Kudenchuk (USA) Ranjit Lall (UK) Shir Lynn Lim (Singapore) Andrew Lockey (UK) David Lockey (UK) Carsten Lott (Germany) Carolina Maciel (USA) Spyros Mentzelopoulos (Greece) Koen Monsieurs (Belgium) Peter Morley (Australia) Laurie Morrison (Canada) Vincent Mosesso (USA) Vinay Nadkarni (USA) Robert Neumar (USA) Tonia Nicholson (New Zealand) Theresa Olasveengen (Norway) Marcus Ong (Singapore) Joseph P. Ornato (USA) Mary Ann Peberdy (USA) Sarah Perman (USA) Joshua Reynolds (USA) Claudio Sandroni (Italy) Comilla Sasson (USA) Kelly Sawyer (USA) Barney Scholefield (UK) Mypinder Sekhon (Canada) Markus Skrifvars (Finland) Alexis A. Topjian (USA) Joseph Varon (USA) Myron L. Weisfeldt (USA) Myra H. Wyckoff (USA) Feng Xu (China) AMSTERDAM–BOSTON–LONDON–NEW YORK– OXFORD–PARIS–SAN DIEGO–ST LOUIS
Volume 175, Supplement 1 (2022 ) Official Journal of the European Resuscitation Council also affiliated with the American Heart Association, the Australian Resuscitation Council, the New Zealand Resuscitation Council, the Resuscitation Council of Southern Africa, and the Japan Resuscitation Council for online access via your library ScienceDirect Available online at www.sciencedirect.com Abstracts of RESUSCITATION 2022 22 - 24 October 2020 Publication of this Abstract Book is supported by the European Resuscitation Council 16–17 June 2022 Antwerp, Belgium RESUSCITATION 2023 02–04 November 2023 Barcelona, Spain Volume 192, Supplement 1 (2023) RESUSCITATION 2025 23rd October – 25th October 2025 Rotterdam, Netherlands Volume 215, Supplement 3 (2025)
Vol . 175 Supplement 1 RESUSCITATION June 2022 CONTENTS Resuscitation is abstracted/indexed by: Current Contents, Science Citation Index, Expanded, Index Medicus, PubMed/Medline and EMBASE. Also covered in the abstract and citation database SCOPUS®. Abstracts for ERC 2022 Best of the Best (BOB) 1 Young Investigator 5 Oral 11 Posters 29 Abstracts for ERC 2023 Young Investigator Award Poster presentation 8 Vol. 192 Supplement 1 November 2023 Abstracts for Resuscitation 2025 Best of the Best S1 Young Investigator Award S6 Oral Abstract Presentation S10 Poster presentation S31 Vol. 215 Supplement 3 November 2025
• Representative of the Governance Committee: Sue Hampshire • Effective NRC representative: Sule Akin • • • • • • • • • • • • Board (voting members): Chair: Federico Semeraro • Chair-elect: Andrew Lockey • Secretary: Nicolas Mpotos • Treasurer: Bernd Böttiger • Director Guidelines and ILCOR: Robert Greif Director External Affairs: Nikolaos Nikolaou • Director Science and Research: Gavin Perkins • Director Training and Education: Carsten Lott • Director Congresses: Giuseppe Ristagno • Editor-in-Chief: Jerry P. Nolan Representative of the Governance Committee: Sue Hampshire • Effective NRC representative: Sule Akin
General Assembly: Board members Science & Education Committees Co-chair Science Co-chair Education BLS Mike Smyth Sander Van Goor ALS Jasmeet Soar Francesc Carmona PLS Dominique Biarent Jana Djakow NLS Marije Hogeveen John Madar IES Silvija Hunyadi-Anticevic Timo De Raad
© 2022 Elsevier B.V. This journal and the individual contributions contained in it are protected under copyright, and the following terms and conditions apply to their use in addition to the terms of any Creative Commons or other user license that has been applied by the publisher to an individual article: Photocopying Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission is not required for photocopying of articles published under the CC BY license nor for photocopying for non-commercial purposes in accordance with any other user license applied by the publisher. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. Permissions For information on how to seek permission visit www.elsevier.com/healthpermissions. Derivative works Users may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions or companies. Other than for articles published under the CC BY license, permission of the publisher is required for resale or distribution outside the subscribing institution or company. For any subscribed articles or articles published under a CC BY-NC-ND license, permission of the publisher is required for all other derivative works, including compilations and translations. storage or usage Except as outlined above or as set out in the relevant user license, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Author rights Author(s) may have additional rights in their articles as set out in their agreement with the publisher (more information at http://www.elsevier. com/authorsrights). Notice Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer. Funding body agreements and policies Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies Disclaimer Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is assumed by Elsevier for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. © 2023 Elsevier B.V. 5
Best of the Best 235 EuReCa-Three Peds: A Europe-Wide Prospective Observational Study on Out-of-Hospital Cardiac Arrest in Children Stephan Katzenschlager1, Inga K. Kelpanides2,3, Ingvild B. M. Tjelmeland4, Jo Kramer-Johansen2,3, Leo Bossaert5,6, Holger Maurer7, Siobhán Masterson8, Rolf Lefering9, Johan Herlitz10, Fernando Rossell Ortiz11, Gavin Perkins6,12,13, JanWnent14,15,16, Jan-Thorsten Gräsner6,14,15 1Department of Anaesthesiology, Heidelberg University, Medical Faculty Heidelberg, Heidelberg, Germany; 2Department of Research and Development, Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway; 3Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; 4Division of Prehospital Services, Oslo University Hospital, Oslo, Norway; 5University of Antwerp, Antwerp, Belgium; 6European Resuscitation Council, Niel, Belgium; 7University Hospital Schleswig-Holstein, Department of Anesthesiology and Intensive Care Medicine, Lübeck, Germany; 8Discipline of General Practice, National University of Ireland Galway (on Behalf of the Out-of-Hospital Cardiac Arrest Register (OHCAR)) and the HSE National Ambulance Service, Galway, Ireland; 9Institut Für Forschung in Der Operativen Medizin (IFOM), Abteilung Statistik Und Registerforschung, Universität Witten/Herdecke, Cologne, Germany; 10Prehospen-Centre for Prehospital Research, Faculty of Caring Science, Work-Life and Social Welfare, University of Boraas, Boraas, Sweden; 11Empresa Pública de Emergencias Sanitarias de Andalucía, Andalucía, Spain; 12Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom; 13University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; 14University Hospital Schleswig-Holstein, Institute for Emergency Medicine, Kiel, Germany; 15University Hospital Schleswig-Holstein, Department of Anaesthesiology and Intensive Care Medicine, Kiel, Germany; 16University of Namibia, School of Medicine, Windhoek, Namibia Purpose: To prospectively assess epidemiology of out-of-hospital cardiac arrest (OHCA) in children across Europe and identify factors associated with survival to hospital discharge. Methods: EuReCa-THREE was a prospective observational trial conducted across 28 nations over three months. Cases with confirmed OHCA and emergency medical services (EMS) treatment were included. Incidence was calculated using official population data. The primary endpoint was survival to hospital discharge; secondary endpoints included survival to hospital admission and any return of spontaneous circulation (ROSC). Multivariate regression analysis was performed, incorporating significant variables from the univariate analysis. For selected parameters, comparisons were made with adults aged18–60. Results: Between 1st September 2022 and 31st November 2022, 445 children (42% female) from 15 countries were included. The annual incidence was 4.3/100,000 children (Range 1.6 to 5.6). Bystander cardiopulmonary resuscitation (CPR) rate was 68% in the pediatric and 65% in the adult population. Overall, 38 (8.5; 0.4/ 100,000) children survived until hospital discharge (Figure 1). Prehospital time intervals didn’t differ between the adult and pediatric populations. Notably, 40% (95% confidence interval [CI] 35–46) were transported under CPR to hospital without achieving ROSC at any point. This differs significantly from adults (14%). Multivariate regression analysis showed adjusted odds ratios (aOR) for survival to hospital discharge of 20.3 (95%CI 7.5–54.6) for initial shockable rhythm, 2.2 (95%CI 0.8–6.2) for bystander-witnessed arrest, and 2.9 (95%CI 0.7–12.3) for EMS-witnessed arrest. Drowning and asphyxia were associated with an improved aOR 16.0 (95%CI 3.3–78.5) and OR 3.5 (95%CI 1.3–9.6), compared to a medical cause. Conclusion: This is the first study on pediatric OHCA across Europe, demonstrating an annual incidence of 4.3/100,000 children. Initial shockable rhythm, drowning, and asphyxia were associated with significantly higher odds of survival. Bystander and EMS-witnessed arrests showed a strong trend towards improved outcomes, although this was not statistically significant in this study. Resuscitation 215S3 (2025) S1–S5 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation 0300-9572
273 Towards Smartwatch-based Automated Cardiac Arrest Detection and Alarming: Development of an Accelerometer-based Model to Detect Cardiac Arrest-related Falls Roos Edgar1, Kambiz Ebrahimkheil2, Danny Meeuwsen3, Maud de Jong1, Bram van den Broek1, Niels Scholte4, Marc Brouwer1, Rypko Beukema1, Eelko Ronner5, Eric Boersma4, Aysun Cetinyurek-Yavuz1, Peter Stas2, Claudine Lamoth6, Niels van Royen1, Judith Bonnes1 1Radboudumc, Nijmegen, Netherlands; 2Corsano Health, The Hague, Netherlands; 3Bottendaal fysiotherapie, Nijmegen, Netherlands; 4Erasmus MC, Rotterdam, Netherlands; 5Reinier de Graaf Hospital, Delft, Netherlands; 6UMC Groningen, Groningen, Netherlands Background: Automated cardiac arrest detection and alerting by a wearable device could facilitate early help in unwitnessed cardiac arrests. In such devices, photoplethysmography (PPG) signals are often used to detect the absence of pulsations, and accelerometer signals to detect ongoing movement. We conducted the DETECT-2 study to develop an accelerometer-based machine learning model for detection of cardiac arrest-related collapse, which is often a first manifestation of cardiac arrest. Figure (abstract 235). Figure 1. (abstract 273): Video screenshots of the instructor demonstrating the fall sideways, while wearing the CardioWatch on the right wrist. Best of the Best / Resuscitation 215S3 (2025) S1–S5 S2
Methods: DETECT-2 was a prospective study in healthy volunteers simulating cardiac arrest-related collapse through sudden falls (forward, backward, sideways [figure 1]) and soft falls (sliding off a chair, via a wall) without subsequent movement. Accelerometer signals were collected with the CardioWatch wristband; video recordings were made as reference standard. An accelerometerbased gradient boosting model (GBM) for fall detection was trained (70%) and validated (30%). The primary endpoint was the sensitivity for the detection of sudden falls. Results: Nineteen participants (9 female, 9 male, 1 non-binary) performed 380 sudden falls. The median age was 23 years old (interquartile range 21–25). In the training set (n = 13; 260 sudden falls), sensitivity of the GBM was 100% (95% confidence interval [CI] 98%–100%), with four false positives. In the validation set (n = 6; 120 sudden falls), sensitivity was also 100% (95% CI 96%–100%), with two false positives. For soft falls, sensitivities were 97.7% (95% CI 93%–99%) and 88.1% (95% CI 76%–95%), respectively. Conclusions: Sudden falls that mimic cardiac arrest-related collapse can be accurately detected using accelerometry data from the CardioWatch. The next step in the development of automated cardiac arrest detection is the integration accelerometer signals into the PPG-based model, with the aim to reduce false positive cardiac arrest alerts and increase sensitivity in everyday use. 288 Patient and Surrogate Perspectives on Consent Procedures in Emergency Trials Tine Bennedsen Gehrt1,2, Birthe Sindberg3, Lars W. Andersen1,2,3, Asger Granfeldt2,3, Ida K. Thomsen3, Pernille T. Rohde4, Mathilde M. Frøslev1, Mikael Fink Vallentin1,2,3 1Prehospital Emergency Medical Services, Central Denmark Region, Aarhus, Denmark; 2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 3Department of Anaesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark; 4Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark Purpose of the Study: In emergency clinical trials, patients may be included with deferred consent regulated under international and national law. Both patients and surrogates must be approached as soon as possible, often during periods of emotional and physical vulnerability. This study explored their perspectives on consent procedures in cardiac arrest emergency trials. Materials and Methods: A three-step qualitative design was applied at a Danish site conducting four cardiac arrest emergency trials with deferred consent in 2024–2025. First, semi-structured interviews were performed 30 days post-arrest with 10 patients, 10 surrogates of survivors, and 7 surrogates of deceased patients. A thematic analysis informed two focus group interviews with an additional 7 patients, 3 surrogates of survivors, and 1 surrogate of a deceased patient. Finally, a six-item, 7-point Likert scale questionnaire was administered immediately after consent procedures to assess realtime perceptions. Participants were unique across all steps. Results: Three themes emerged across interviews: (1) the relative value of oral versus written trial information, (2) emotional and physical vulnerability at the time of consent, and (3) motivations for participation. Focus groups confirmed data saturation. Questionnaire results showed oral information was rated more helpful than written (median 7 [IQR: 6–7] vs. 3.5 [IQR: 1–7]). A feeling of being ready for consent procedures was high (median 6 [IQR: 4–7]), while feelings of emotional chaos showed high variance (median 5 [IQR: 1–7]). Altruistic motivations were strong, with participants citing a desire to improve treatment for future patients (median 7 [IQR: 7–7]) and support research in general (median 7 [IQR: 7–7]). Conclusions: Patients and surrogates approached for deferred consent after cardiac arrest reported varying emotional chaos but a high degree of readiness. Oral information was emphasized over written materials. These findings may inform clinicians who carry out deferred consent procedures. 421 Epidemiology of EEG Patterns in Comatose Patients After Cardiac Arrest and Association with Long-Term Outcome Giacomo Abbiati1, Matteo Pozzi1,2, Gianmarco Carenini1, Valentina Piazza2, Marco Normanno2, Ilaria Mariani2, Francesco Gaiani2, Marco Giani1,2, Simone Tagliabue1, Jacopo DiFrancesco1,2, Angela Giglio1, Carlo Morotti Colleoni1, Giulia Cereda1, Giulia Pederzoli1, Simone Beretta1,2, Giuseppe Foti1,2 1Università degli Studi di Milano-Bicocca, Milano, Italy; 2IRCCS San Gerardo dei Tintori, Monza, Italy Aim: Hypoxic-ischemic brain injury is a leading cause of inhospital mortality following cardiac arrest (CA). Current neuroprognostication algorithms include highly malignant EEG patterns (burstsuppression or suppression with or without generalized periodic discharges [GPDs]). However, the association between outcome and other epileptic patterns is less established. This study aims to evaluate the association between early EEG patterns and 6-month neurological outcomes. Methods: We conducted a prospective observational study of patients admitted to the cardiac ICU at IRCCS San Gerardo Hospital between January 2011 and December 2024 after CA. All patients received targeted temperature management and continuous EEG monitoring. EEGs between 24 h and 48 h were categorized into four exclusive patterns: Benign (continuous/reactive background, no status epilepticus [SE] or GPDs). SE (no GPDs). GPDs. Malignant (discontinuous/unreactive background, no SE or GPDs). Multimodal prognostic data included peak neuron-specific enolase (NSE) at 24–48 hours. The primary outcome was a good neurological outcome at 6 months (CPC 1–2). Results: Of 652 enrolled patients, 477 were included in the analysis. Outcomes were favorable in 63.4% with benign and 26.2% with SE patterns (Table 1). In multivariable analysis, age (OR 0.94; p < 0.0001), NSE (OR 0.97; p < 0.0001), and EEG pattern (benign vs others: OR 2.79; SE vs GPDs/malignant: OR 6.15; p = 0.0378) were independently associated with good outcomes (Figure 1). Periodic and malignant patterns were associated with higher NSE levels, while no difference was observed between benign and SE (Figure 2). Best of the Best / Resuscitation 215S3 (2025) S1–S5 S3
Conclusion: EEG patterns, particularly benign and SE, are independently associated with improved outcomes after CA and lower NSE levels. Incorporating predefined, simple EEG patterns into multimodal prognostic frameworks may reduce uncertainty and improve clinical decision-making. References 1. Turella S et al. EEG for good outcome prediction after CA. Resuscitation. 2023;202:110319. 2. Beretta S et al. Neurologic outcome after postanoxic SE. Neurology. 2018;91(23):e2153–e2162. 424 Effectiveness of Real-Time Feedback, Debriefing, and Retraining System for Patients with Out-of-Hospital Cardiac Arrest: A Cluster Parallel-Group Randomized Controlled Trial Norihiro Nishioka1,2, Ryuta Onodera1, Takefumi Kishimori3, Toshihiro Hatakeyama4, Daisuke Kobayashi5, Takeyuki Kiguchi6, Chika Nishiyama1, Taku Iwami1 1Kyoto Univesity, Kyoto, Japan; 2Kyorin University, Mitaka, Japan; 3Omi Medical Center, Kusatsu, Japan; 4Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan; 5Ritsumeikan University Medical Service Center, Kyoto, Japan; 6Osaka General Medical Center, Osaka, Japan Purpose: This study aimed to evaluate whether a cardiopulmonary resuscitation (CPR) support system integrating real-time feedback, post-event debriefing, and retraining improves CPR quality for patients with out-of-hospital cardiac arrest (OHCA). Materials and Methods: We conducted a cluster parallel-group randomised controlled trial across 51 fire stations within six fire departments in Japan. From July 2017 to March 2024, a total of 3,101 adult patients (aged ≥18 years) who experienced OHCA and received CPR from emergency medical services were enrolled. All medical aetiologies of OHCA were included. Fire stations were randomly allocated to either an intervention group (27 stations, 1,472 patients), equipped with a CPR support system including real-time feedback, debriefing, and retraining, or a control group (24 stations, 1,629 patients) that followed conventional protocols. The evaluated outcomes included achievement rates of chest compression fraction (CCF) ≥80%, compression depth of 5–6 cm, and compression rate of 100– 120/min. Analyses followed the intention-to-treat principle using generalized estimating equations. Results: Compared to the control group, the intervention group showed significantly higher achievement rates for appropriate compression depth (odds ratio [OR] = 1.34, 95% confidence interval [CI]: 1.13–1.58) and compression rate (OR = 2.25, 95% CI: 1.86–2.72). The proportion achieving CCF ≥80% did not differ between groups (OR = 1.04, 95% CI: 0.85–1.26). Table (abstract 421). Best of the Best / Resuscitation 215S3 (2025) S1–S5 S4
Conclusions: The CPR support system with real-time feedback, debriefing, and retraining significantly improved CPR quality in terms of compression depth and rate but did not affect CCF. These results support the integration of such systems into EMS practice and training to enhance CPR performance. Trial Registration: UMIN Clinical Trials Registry (UMIN000021431). Best of the Best / Resuscitation 215S3 (2025) S1–S5 S5
Young Investigator Award 210 Evaluating Functional Outcome in Patients with Discordant Prognostic Signs Following Cardiac Arrest Alice Lagebrant1,2, Claudio Sandroni3,4, Antonello Grippo5, Byung Kook Lee6,7, Niklas Nielsen1,8, Chun Song Youn9, Tobias Cronberg1,10, Marion Moseby-Knappe1,11 1Department of Clinical Sciences Lund, Lund University, Lund, Sweden; 2Department of Neurology, Skåne University Hospital, Malmö, Sweden; 3Department of Intensive Care, Emergency Medicine and Anaesthesiology, Fondazione Policlinico Universitario “Agostino Gemelli”-IRCCS, Rome, Italy; 4Institute of Anaesthesiology and Intensive Care Medicine, Università Cattolica del Sacro Cuore, Rome, Italy; 5SODc Neurofisiopatologia, Neuroscience Department, Careggi University Hospital, Florence, Italy; 6Department of Emergency Medicine, Chonnam National University Medical School, Gwangju, Korea, Republic of; 7Department of Emergency Medicine, Chonnam National University Hospital, Gwangju, Korea, Republic of; 8Department of Anesthesia and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden; 9Department of Emergency Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of; 10Department of Neurology, Skåne University Hospital, Lund, Sweden; 11Department of Rehabilitation, Skåne University Hospital, Lund, Sweden Purpose: To explore functional outcome of unconscious cardiac arrest patients in whom favourable and unfavourable predictors of neurological prognosis coexist. Methods: Post-hoc descriptive analysis of four prospective multicentre studies (TTM, TTM2, KORHN and ProNeCA). We evaluated patients with discordant predictors after cardiac arrest. Unfavourable predictors included the 2021 ERC/ESICM criteria for poor outcome: highly malignant electroencephalography (EEG), absent N20-wave on somatosensory-evoked potentials (SSEP), neuron-specific enolase (NSE) > 60 µg/L at 48/72 hours (h), hypoxic-ischaemic brain injury (HIBI) on computed tomography (CT)/magnetic resonance imaging (MRI), absent pupillary light and corneal reflexes (PLR/CR) and status Figure (abstract 210). Resuscitation 215S3 (2025) S6–S9 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation 0168-8278
myoclonus < 72h). Favourable predictors included ILCOR-suggested criteria: Glasgow Coma Scale-Motor (GCS-M) 4-5, NSE < 17 µg/L at ≤72h, benign EEG patterns ≤72h and normal MRI at 72-168h. Functional outcome was assessed at six months. Results: We included 3388 out-of-hospital cardiac arrest patients with available functional outcome and GCS-M ≥72h. Of 2445 unconscious (GCS-M<6) patients, 131 (5%) had discordant predictors (64 (SD13) years, 88 males (67%), 25 (IQR18-38) minutes to ROSC). Fourty-two (32%) patients had a good outcome at six months. At least one coexisting good outcome predictor and absent PLR/CR, N20 SSEP waves or NSE levels >60 ug/L were associated with neurological recovery in 13% (3/24), 17%(2/12) and 25% (5/20), respectively. HIBI in presence of at least one good outcome predictor was associated with good outcome in 67% (12/18) for CT but only 18% (2/11) for MRI. Conclusion: Patients with discordant predictors can survive with good outcome after cardiac arrest, confirming the ERC/ESICM guidelines to observe and reevaluate these patients to avoid inappropriate treatment limitations. 275 Automated Cardiac Arrest Detection using Wearable Technology - Descriptive Analysis of False Positive Cardiac Arrest Alerts Emma Hulshof1, Roos Edgar1, Catharina Jansen1, Kambiz Ebrahimkheil2, Niels Scholte3, Aysun Cetinyurek-Yavuz1, Eelko Ronner4, Eric Boersma3, Peter Stas2, Niels van Royen1, Judith Bonnes1 1Radboudumc, Nijmegen, Netherlands; 2Corsano Health, The Hague, Netherlands; 3Erasmus MC, Rotterdam, Netherlands; 4Reinier de Graaf Hospital, Delft, Netherlands Background: Survival from out-of-hospital cardiac arrest depends on timely recognition and early cardiopulmonary resuscitation. The DETECT project aims to develop a wristband with automated cardiac arrest detection that can alert emergency medical services (EMS). In the DETECT-1a study, a photoplethysmography (PPG)-based algorithm was developed in patients with induced cardiac arrest. Sensitivity was excellent, but false positives must be reduced to prevent unnecessary EMS alerts. This study describes characteristics of false positive alerts encountered in the DETECT studies. Methods: All false positive cardiac arrest alerts from the DETECT-1a study were analyzed, supplemented by alerts from healthy volunteers who wore the wristband in everyday life. Continuous electrocardiogram and intra-arterial pressure data were available as reference for DETECT-1a participants. The algorithm had to detect arrest within five seconds. Alerts occurring in the absence of induced or actual cardiac arrest were classified as false positive. Features extracted included alert duration, PPG signal amplitude, and, if available, mean arterial pressure (MAP) and heart rhythm. These features were determined before and during the false positive alert. Results: A total of 42 false positive alerts from 25 participants were analyzed. The median alert duration was 25 seconds (IQR 13–43), after which the algorithm recognized spontaneous pulses and terminated the alerts. Thirty-four alerts (80%) showed a decreased PPG signal amplitude compared to preceding signal, with an average decline of 81%. Among alerts with reference data (n = 23), 18 (78%) showed a decrease in MAP compared to preceding segments, often due to procedure-related arrhythmias. Conclusion: Wearable-based false positive cardiac arrest alerts were short in duration and partly caused by transient hemodynamic changes. Based on these findings, extending the detection interval to allow redetection of pulsations is expected to reduce false positives. If confirmed while preserving sensitivity, this adjustment could enable reliable automated cardiac arrest detection and potentially improve survival. 423 When the Heart Fails, Does Stellate Ganglion Block Follow? Role of Cardiac Disease and Left Ventricular Dysfunction Alessia Currao1,2, Bianca Citterio3,4, Margherita Paggi1,4, Elisa Gianino3,4, Silvia Miette Pontremoli3,4, Veronica Dusi5,6, Gaetano Maria De Ferrari5,6, Filippo Angelini5,6, Edoardo Gandolfi7, Matteo Casula8, Lucy Barone9, Gabriele Dell’Era10, Francesco Notaristefano11, Giuseppe D’Angelo12, Roberto Rordorf3, Enrico Baldi3, Simone Savastano3 1Fondazione IRCCS Policlinico San Matteo, Division of Cardiology, Pavia, Italy; 2University of Pavia, Department of Internal Medicine and Medical Therapy, Pavia, Italy; Figure (abstract 275). Young Investigator Award / Resuscitation 215S3 (2025) S6–S9 S7
3Fondazione IRCCS Policlinico San Matteo of Pavia, Division of Cardiology, Pavia, Italy; 4University of Pavia, Department of Molecular Medicine, Pavia, Italy; 5Molinette Hospital, Città della Salute e della Scienza of Turin, Division of Cardiology, Torino, Italy; 6University of Torino, Dept of Medical Sciences, Torino, Italy; 7Santi Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy, Division of Cardiology, Alessandria, Italy; 8”San Michele” dell’ARNAS “G. Brotzu Hospital, Cagliari, Italy; Division of Cardiology, Cagliari, Italy; 9”Tor Vergata” University Hospital, Rome, Italy; Division of Cardiology, Roma, Italy; 10Maggiore della carità Hospital, Novara, Italy, Novara, Italy; 11Santa Maria della Misericordia Hospital, Perugia, Italy, Division of Cardiology, Perugia, Italy; 12IRCCS San Raffaele Hospital, Milan, Italy, Division of Cardiology, Milano, Italy Purpose: Percutaneous Stellate Ganglion Block (PSGB) is a promising treatment for the management of electrical storm. Nevertheless, its effectiveness in relation to the type of underlying heart disease and the extent of cardiac dysfunction is not yet well established. Materials and Methods: We considered PSGB performed from July 1, 2017 to April 30, 2024 across 19 italian Centres. Procedures were stratified according to the tertiles of left ventricular ejection fraction (LVEF) prior to the procedure (T1: LVEF <20%; T2: LVEF 20–33%; T3: LVEF >33%). Patients were categorized based on the type of heart Figure (abstract 423). Young Investigator Award / Resuscitation 215S3 (2025) S6–S9 S8
disease and the presence of shock, cardiogenic or septic. The number of treated ventricular arrhythmias pre and post PSGB was compared. Results: Of 254 PSGB, pre-procedure LVEF was available in 244 cases. The rate of complete arrhythmic suppression at 1 h post-PSGB was comparable (T1: 82%, T2: 86%, T3: 89%, p = 0.39). LVEF was not associated with the likelihood of complete arrhythmic suppression [T1: reference; T2: OR 1.4 (95% CI: 0.6–3.2), p = 0.45; T3: OR 1.9 (95% CI: 0.7–4.7), p = 0.18]. A total of 180 patients were treated: 53 with acute coronary syndrome (ACS), 67 with ischemic cardiomyopathy (IC), 41 with non-ischemic cardiomyopathy (NIC) and 19 with miscellaneous conditions (excluded); 48 experienced shock. The rate of complete suppression of arrhythmias at 12 h post-PSGB was similar (ACS: 57%, IC: 69%, NIC: 68%, p = 0.3). Neither underlying heart disease [ACS: ref; IC: OR 2.1 (0.9–4.9), p = 0.09; NIC: OR 1.6(0.7–3.9), p = 0.3], nor the presence of shock [OR 2.1(0.9–4.9), p = 0.08], were associated with the likelihood of complete arrhythmia suppression. The arrhythmic burden was significantly reduced in all the subgroups (figure 1). Conclusions: PSGB is a powerful and effective treatment for electrical storm, regardless of left ventricular dysfunction, underlying heart disease, or presence of shock, supporting its use even in the most critical cases. 453 Associations between Barriers Specific to Optimal Resuscitation, Teamwork, and Communication During In-Hospital Resuscitation Attempts and Chest Compression Quality Freia Agervig1,2, Anna V. Østergård1,2, Amalie R. Gedde1,2, Johannes Wittig2,3,4, Moritz Nettinger2,5, Sune D. Müller6, Vinay M. Nadkarni7, Bo Løfgren2,4, Kasper G. Lauridsen2,3,4,7,8 1Aarhus University, Aarhus, Denmark; 2Research Center for Emergency Medicine, Aarhus University Hospital, Aarhus, Denmark; 3Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 4Department of Medicine, Randers Regional Hospital, Randers, Denmark; 5Paracelsus Medical University, Salzburg, Austria; 6Department of Informatics, University of Oslo, Oslo, Norway; 7Department of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA; 8Department of Anaesthesiology and Intensive Care, Randers Regional Hospital, Randers, Denmark Purpose: Barriers and errors frequently occur during in-hospital cardiac arrests (IHCA) and may be associated with chest compression quality. However, whether the impact differs depending on the reason for barriers remains unknown. We aimed to investigate associations between reported barriers to optimal resuscitation, teamwork, and communication during IHCA resuscitation attempts and chest compression quality. . Methods: Data were collected through post-arrest debriefing surveys as part of a prospective, multicentre cohort study (May 2017–April 2022) across four hospitals in the Central Denmark Region. We analysed reported barriers in surveys (free text comments and Likert scale ratings) according to three predefined categories: (1) optimal resuscitation, (2) teamwork, (3) communication. Survey data were matched with defibrillator data, including the longest chest compression pause in seconds, chest compression fraction (CCF) ≥80%, and guideline-compliant chest compression rates. Results: A total of 313 IHCAs were included, of which 133 (42.5%) reported barriers. A total of 212 barriers were reported across all three categories; 88 (41.5%) were barriers to optimal resuscitation, 57 (26.9%) to teamwork, and 67 (31.6%) to communication. Barriers to teamwork and optimal resuscitation were not significantly associated with either the longest pause duration (optimal resuscitation: β= 0.93 sec; 95% CI: −5.3–7.17 vs teamwork: β= -2.89 sec; 95% CI: −9.8–4.05), a CCF≥80% (optimal resuscitation: OR = 0.81; 95% CI: 0.47–1.40 vs teamwork: OR = 1.01; 95% CI: 0.55–1.87), or chest compression rate. Communication barriers were not significantly associated with longest pause duration (β= 2.16 sec; 95% CI: −4.44– 8.8) but showed a trend towards being associated with not achieving a CCF≥80% (OR = 0.60; 95% CI: 0.34–1.08) and were significantly associated with non-guideline-compliant chest compression rates (OR = 0.46; 95% CI: 0.25–0.86; p = 0.01). Conclusion: Barriers related to communication appeared to have a greater impact on chest compression rates and chest compression fraction than barriers related to teamwork and optimal resuscitation during IHCA. Young Investigator Award / Resuscitation 215S3 (2025) S6–S9 S9
Oral Abstract Presentation 9 The Peak End-tidal Carbon Dioxide Concentration Recorded during Cardiopulmonary Resuscitation as an Indicator of Survival: a Nationwide Cohort Study of Pediatric Out-of-Hospital Cardiac Arrests Recher Morgan1, Canon Valentine2, Lockhart-Bouron Marguerite1, Hubert Hervé2, Javaudin François3, Leteurtre Stéphane1, Mitha Ayoub4 1University Hospital of Lille, Lille, France; 2University of Lille, Lille, France; 3University Hospital of Nantes, Nantes, France; 4University Hospital of Tours, Tours, France Background: Although the end-tidal carbon dioxide concentration (ETCO2) recorded during resuscitation has been reported as an indicator of survival in a few studies of pediatric in-hospital cardiac arrest, the relationship between ETCO2 and survival in pediatric outof-hospital cardiac arrest (OHCA) has not previously been investigated. This study aimed to determine whether measurement of ETCO2during resuscitation is predictive of survival during pediatric OHCA. Method: This nationwide, population-based cohort study analyzed data from the French RéAC OHCA registry, including all patients under 18 years of age with trauma-related OHCA or medical OHCA from 2011 to 2023. The highest ETCO2 value was recorded. The main outcomes were return of spontaneous circulation (ROSC) and day (d)30 survival. Discriminant ability was evaluated using the area under the receiver operating characteristic curve (AUROC), and the Youden index was used to determine the optimal ETCO2 cut-off value. Results: A total of 1209 pediatric OHCAs (226 (19%) trauma-related and 983 (81%) medical) were included. The victims’ median [interquartile range] age was 6 [0;14] years. ROSC was achieved in 347 (29%) cases and d30 survival was achieved in 61 (5%) cases. In both trauma-related and medical OHCAs, the peak recorded ETCO2 value was higher in patients who achieved ROSC and in d30 survivors. The AUROC [95% confidence interval] for the highest ETCO2 that predicted ROSC and d30 survival were respectively 0.808 [0.745–0.872] and 0.854 [0.761–0.947] for the trauma-related OHCA group and 0.803 [0.774–0.831] and 0.732 [0.676–0.787] for the medical OHCA group. In both groups, the probability of ROSC and d30 survival increased with higher ETCO2 values, with optimal cut-offs of 21 and 29 mmHg for trauma-related OHCA and 27 and 26 mmHg for medical OHCA, respectively. Conclusions: These findings serve as a basis for new guidelines on monitoring ETCO2 during pediatric cardiopulmonary resuscitation. 24 The Role of the Immune System in Hypoxic Ischemic Brain Injury Following Cardiac Arrest Lauren Maier1, Jordan Bird1, Chloe Allen1, Rebecca Grey2, Sophie Stukas1, Ryan Hoiland1, Donald Griesdale2, Mypinder Sekhon1,2 1Department of Medicine, University of British Columbia, Vancouver, Canada; 2Critical Care Medicine, Vancouver General Hospital, Vancouver, Canada Hypoxic ischemic brain injury (HIBI) is a devastating secondary injury following resuscitation from cardiac arrest1 and is the primary determinant of outcomes.2 The innate immune response to sterilely injured tissue may play an important role in HIBI.3 Thus, this study investigated the immune response to cerebral ischemia –reperfusion inHIBI. We conducted a prospective observational study in 34 post-cardiac arrest patients with invasive neuromonitoring. We dichotomized the cohort into survivors versus non-survivors and those experiencing brain tissue hypoxia versus normoxia. Paired blood samples from arterial and jugular venous bulb catheters were collected to calculate transcerebral release of biomarkers of neurovascular injury and inflammation. Invasive multimodal neuromonitoring consisted of brain tissue oxygen tension (PbtO2), intracranial pressure (ICP), cerebral perfusion pressure (CPP), and jugular venous bulb oxygen saturation (SjvO2). Data are presented as median (interquartile range [IQR]). Cerebrovascular physiology (ICP, CPP, PbtO2, orSjvO2) did not differ between hypoxic and normoxic HIBI patients (18H/16N), or survivors and non-survivors (12S/22N). Interleukin-1β (IL-1β) arterial concentration was similar between hypoxic and normoxic HIBI patients (p = 0.25). Similarly, IL-6 was not different between groups (hypoxic: 14.9 [6.3–23.5] pg/mL vs. normoxic: 19.0 [14.0–28.4] pg/mL; p = 0.44), nor was tumor necrosis factor a (TNFa) (hypoxic: 2.2 [1.6–3.2] pg/mL vs. normoxic: 3.3 [1.9–5.0] pg/mL; p = 0.21). In HIBI survivors, arterial IL-1β, IL-6, and TNFa were not different from non-survivors (p = 0.63, p = 0.69, p =0.29, respectively). We observed similar concentrations and patterns in the venous circulation, resulting in negligible arterialvenous gradient differences. We observed no differences in pro-inflammatory cytokines between hypoxic and normoxic HIBI patients or survivors and nonsurvivors. These data suggest the innate immune response to cerebral ischemia-reperfusion may not influence HIBI outcomes. Resuscitation 215S3 (2025) S10–S30 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation 0300-9572
References 1. Sekhon MS, et al. Critical Care 2017;21:90. 2. Gräsner JT, et al. Resuscitation2016;105:188–95. 3. Sekhon MS, et al. J Physiology 2024;602:5731–44. 31 Chest Compression Synchronized Ventilation Compared to 3:1 Compression: Ventilation Ratio during Neonatal Cardiopulmonary Resuscitation in Asphyxiated Newborn Piglets –a Randomized Animal Trial Shrieya Praveen, Megan O’Reilly, Raza Hyderi, Marwa Ramsie, Tze-Fun Lee, Georg Schmölzer University of Alberta, Edmonton, Canada Purpose of the Study: Current neonatal resuscitation guidelines recommend 3:1 Compression: Ventilation ratio (3:1 C:V) during cardiopulmonary resuscitation. One of the concerns with 3:1 C:V is lung derecruitment, which contributes to a delay in achieving return to spontaneous circulation (ROSC). An alternative approach might be chest compression synchronized ventilation (CCSV), which delivers a ventilation with each chest compression thereby achieving lung recruitment. Our hypothesis was: In asphyxiated newborn piglets with cardiac arrest does CCSV vs 3:1 C:V decrease the time to ROSC. Materials and Methods: Sixteen newborn piglets (n = 8/group, 0–3 days old) were anesthetized, intubated, instrumented, and exposed to 45-minute normocapnic hypoxia, followed by asphyxia. Piglets were randomized to either CCSV or 3:1 C:V. Piglets assigned to CCSV received 100–120 compressions/min with a ventilator-synchronized inflation delivered during every compression (CCSV-Mode, Weinmann Germany). In the 3:1 C:V group, piglets received 90 compressions/min and 30 ventilations/min. Compressions and ventilations were continued until ROSC. Continuous respiratory parameters, cardiac output, mean systemic artery pressures, and blood flows were measured Results: Age and weight were similar between groups. The median (IQR) asphyxia time was not significantly different between CCSV (326 (275–405))sec and 3:1 C:V (416 (266–475))sec (p = 0.442). Time to ROSC was significantly lower using CCSV with 68 (50–125) sec vs 170 (105–312) sec with 3:1 C:V (p = 0.030). Rate of ROSC was 6/8 with CCSV and 5/8 with 3:1 C:V (p = 1.000). Conclusions: In a neonatal piglet model of asystolic cardiac arrest, CCSV resulted in a significantly faster time to ROSC compared to 3:1 C: V. Using CCSV might be an alternative to 3:1 C:V for neonatal resuscitation, but further studies are warrented. 41 Use of Auto Transfusion Turniquet Increases End-tidal-CO2 in Outof-Hospital Cardiac Arrest Patients Maruša Esih1, Noam Gavriely2,3, Matej Strnad1,4,5 1University Medical Centre Maribor, Maribor, Slovenia; 2Israel Institute of Technology, Haifa, Israel; 3OHK Medical Devices Ltd., Tirat Carmel, Israel; 4Center for Emergency Medicine, Maribor, Slovenia; 5Department of Emergency Medicine, Medical Faculty, University of Maribor, Maribor, Slovenia Objectives: Out-of-hospital cardiac arrest (OHCA) remains a leading cause of mortality, with low survival rates despite advancements in cardiopulmonary resuscitation (CPR) and emergency care. This study aimed to evaluate the safety and effectiveness of the HemaShock®Auto-Transfusion Tourniquet (A-TT) in OHCA patients by assessing its impact on perfusion during resuscitation, measured via end-tidal CO2 partial pressure (PetCO2). Methods: This was a prospective, randomized controlled study conducted in the pre-hospital setting of Maribor, Slovenia. Twentyfour OHCA patients were enrolled and divided into two groups: 12 patients received standard advanced cardiac life support (ACLS) plus A-TT (Study Group), while 12 received only ACLS (Control Group). The primary outcome was the difference in PetCO2 before and after A-TT application (p < 0.05). Safety was assessed by validating that quality parameters of CPR in standard resuscitation protocols were not affected by the use of A-TT. Results: There were no significant differences between the two groups regarding demographic factors, morbidity, or prehospital treatment. A-TT was successfully applied in 12 patients, with one case of ineffective exsanguination. Return of spontaneous circulation (ROSC) was achieved in 50% of the Study Group and 33% of the Control Group (NS). PetCO2 increased by 24.8% (P < 0.005) immediately after A-TT application, sustaining for 5 minutes before returning to baseline. No adverse effects on ACLS delivery or patient management were observed. Conclusions: The use of A-TT in OHCA patients was safe and did not interfere with ACLS protocols. The significant increase in PetCO2 suggests improved tissue perfusion during resuscitation, though the effect was transient. Earlier application of A-TT may enhance its benefits. Further studies with larger sample sizes are needed to assess its impact on survival and neurological outcomes. 83 Vital Signs Preceding in-hospital Cardiac Arrest: a Matched Casecontrol Study Frederik Gautier Hansen1,2, Peter Carøe Lind1,2,3, Nikola Stankovic1,2,4, Mathias Johan Holmberg1,2, Lars Wiuff Andersen1,2,5, Asger Granfeldt1,2 1Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 2Department of Anaesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark; 3Department of Anaesthesiology and Intensive Care, Gødstrup Hospital, Gødstrup, Denmark; 4Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark; 5Prehospital Emergency Medical Services, Central Denmark Region, Denmark Background: Hospitalised patients have routine vital sign measurements to detect clinical deterioration. Research into pre-inhospital cardiac arrest vital signs is crucial, as early detection can enable timely intervention and potentially prevent cardiac arrest. This study aimed to investigate the association between vital signs and the risk of in-hospital cardiac arrest. Materials and Methods: We conducted a registry-based matched case-control study, including cases with in-hospital cardiac arrest and hospitalized patients as controls, in the Central Denmark Region from 2017–2022. Exposures were values of heart rate, systolic and diastolic blood pressure, body temperature, respiratory rate, level of consciousness,SpO2, pulse pressure, SpO2/FiO2ratio, and National Early Warning Score (NEWS) 2. Conditional logistic regression was used to assess the associations between continuous and categorical values of vital sign measurements and the risk of in-hospital cardiac arrest. Results: The study population consisted of 1,587 cases and 10,276 controls. The median age was 74 (IQR: 66–81) years and 66% were male. Median time from vital sign measurement to index time was 4 (IQR:1–8) hours for cases and 8 (IQR: 4–13) hours for controls. The risk of in-hospital cardiac arrest increased incrementally for increasing Oral Abstract Presentation / Resuscitation 215S3 (2025) S10–S30 S11
heart rate, body temperature, respiratory rate, and NEWS 2 score, and decreasing systolic and diastolic blood pressure, body temperature, SpO2, pulse pressure, and SpO2/FiO2 ratio. No associations were found for systolic hypertension and high pulse pressure. Associations were most pronounced for systolic blood pressure≤80 mmHg (OR 15.3 [95% CI: 9.44–24.7]), SpO2/FiO2≤2.50 (OR 14.1 [95% CI: 10.3–19.2]), and NEWS 2 score≥7 points (OR 11.7 [95% CI: 9.57–14.3]) compared to normal reference values. Conclusion: The risk of in-hospital cardiac arrest increases incrementally with the degree of vital sign abnormality. 129 Why Do Patients Develop In-Hospital Cardiac Arrest? A Prospective Clinical Study (WHY-IHCA) Peter Carøe Lind1,2,3, Benjamin Hørning Risager1,2, Henrik Gammelager2, John Bro-Jeppesen4, Mads Svart5, Lene Warner Throup Boel6, Charlotte Uggerhøj Andersen6, Jørgen Bo Hasselstrøm6, Rozh Al-Mashhadi1,7, Tomas Frahm Nielsen7, Lars Wiuff Andersen1,2,8, Asger Granfeldt1,2 1Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 2Department of Anaesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark; 3Department of Anaesthesiology and Intensive Care, Gødstrup Hospital, Gødstrup, Denmark; 4Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; 5Steno Diabetes Centre, Aarhus University Hospital, Aarhus, Denmark; 6Department of Forensic Medicine, Aarhus University, Aarhus, Denmark; 7Department of Radiology, Aarhus University Hospital, Aarhus, Denmark; 8Prehospital Emergency Services, Central Denmark Region, Aarhus, Denmark Purpose of study: No previous study has described in-hospital cardiac arrest (IHCA) aetiologies prospectively through a protocolised investigation. In this study, we investigated IHCA aetiologies through a protocolised investigation in both IHCA patients achieving return of spontaneous circulation (ROSC) as well as IHCA patients not achieving ROSC. Materials and methods: Adult IHCA patients were included at Aarhus University Hospital in Aarhus, Denmark. In patients with ROSC, the protocolised investigation consisted of blood tests including toxicology, echocardiography, and whole-body computed tomography (CT). In patients without ROSC, the investigation consisted of blood tests including toxicology and a“virtual autopsy” consisting of wholebody CT- and magnetic resonance imaging (MRI). The primary outcome was the IHCA aetiology as determined by a four-person expert panel based on the protocolised investigations as well as clinical history. A key secondary outcome included the presumed aetiology as determined by cardiac arrest team leaders. Results: A total of 150 patients were included from April 2023 to February 2025. Of these, 71 (47%) achieved ROSC. The median age was 71 years and 62% were male. Expert panel IHCA aetiologies were predominantly cardiac (27–30% across experts) and pulmonary (25– 34% across experts) with myocardial ischaemia and hypoxia being the most prevalent specific aetiologies (10–15% and 13–25% across experts, respectively). Across experts, the aetiology was deemed unknown in 0–14% of cases, and the protocolised investigation contributed to disclosing the IHCA aetiologies in 14–76% of cases. These included post-mortem MRI- and CT-scans showing evidence of aortic dissection, pulmonary emboli, exsanguination, and pericardial tamponade in patients where these were not presumed clinically. Presumed aetiologies were deemed as unknown in 26% of cases but otherwise showed similar distributions. Conclusion: The predominant aetiologies of IHCA are of pulmonary and cardiac nature. A protocolised investigation, including postmortem investigations, aided in disclosing IHCA aetiologies. 141 Cardiac Arrest Survivors Wishes, Needs, and Preferences for a Digital Support Program–An Interview Study Annette Waldemar1, Anders Bremer2, Ingela Thylén3, Johan Israelsson2 1Linköpings universistet and Cardiology Department, Norrköping, Sweden; 2Linneuniversitetet, Kalmar, Sweden; 3Linköpings universistet and Cardiology department, Linköping, Sweden Purpose: Cardiac arrest survivors often face cognitive, physical, psychological, and existential challenges. Many report insufficient follow-up care and difficulty finding reliable information and support. Our research aims to co-design and evaluate a digital support and educational programme to assist survivors manage life after cardiac arrest. As part of this co-design process, the purpose of this study was to explore survivors’ views on what content would be most helpful and how it should be structured and presented to complement existing care. Materials and methods: This qualitative study was approved by the Swedish Ethical Review Authority (No. 2024-01840-01). Eight women and 12 men (aged 44–80) participated, recruited from a national patient network for cardiac arrest survivors. Time since cardiac arrest ranged from 3 months to 19 years. Data were collected between November 2024 and February 2025 through three individual and four focus group interviews, and analysed using qualitative content analysis. Results: Five themes were identified: Support Program Formalities, The Care Process, Heart and Lung Diseases, Physical and Emotional Consequences, and A New Everyday Life. Survivors emphasized the need for short, simple texts, audio options, clear language, and videos. Key topics included ambulance and hospital care, fear of movement, pain, sleep difficulties, and psychological issues. Participants also wanted information on how lifestyle factors affect the heart and available treatments options. Cognitive impairment and fatigue should be addressed, as personality changes can affect relationships. Family members and bystanders are also deeply affected, and participants stressed that they should be supported through a dedicated module. Conclusions: There is a clear need for digital support among cardiac arrest survivors. The interviews provide valuable guidance on relevant content required and designed. The digital support and educational programme should be clear, accessible, informative, and address survivors’ and families’ physical, cognitive, and emotional needs. 142 Ready2Revive Pilot: Feasibility of Brief Basic Life Support Training in Everyday Settings Sonali Munot1, Andrew Coggins2, Adrian Bauman3, Simone Marschner1, Kelly Chan1, Janet Bray4, Clara K Chow1 1Westmead Applied Research Centre, The University of Sydney, Westmead, Australia; 2Department of Emergency Medicine, Westmead Hospital, Westmead, Australia; 3School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Oral Abstract Presentation / Resuscitation 215S3 (2025) S10–S30 S12
RkJQdWJsaXNoZXIy MjYwNTA2Mw==